MPM BioImpact LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
MPM BioImpact LLC
CIK #0001687078
Sector Form 13F Holdings Value ($M)
DBV Technologies Sa 108.9
Cullinan Oncology Inc 108.7
Liquidia Corp 53.0
Alumis Inc 52.6
Edgewise Therapeutics Inc 52.3
Revolution Medicines Inc 49.3
Agios Pharmaceuticals Inc 44.2
Corcept Therapeutics Inc 39.7
Trevi Therapeutics Inc 39.4
Magenta Therapeutics Inc 35.6
View All
Holdings by Sector ($M)
1300104078052026002019202120242027
EDGAR Form CIK 2011 - 2026
13F-HR [0001687078]
3 [0001687078]
4 [0001687078]
SC 13D [0001687078]
SC 13G [0001687078]
Form 13D/13G Filer Form 13D/13G Subject Filed
MPM Bioimpact LLC Forte Biosciences Inc [2026-05-15]
MPM Bioimpact LLC DBV Technologies Sa [2026-02-17]
MPM Bioimpact LLC Climb Bio Inc [2026-02-17]
MPM Bioimpact LLC Compass Therapeutics Inc [2025-02-14]
MPM Bioimpact LLC Context Therapeutics Inc [2025-01-08]
Bioimpact Capital LLC Reunion Neuroscience Inc [2023-06-12]
Form 3/4/5 Subject 2011 - 2026
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Innovations Fund LP
Werewolf Therapeutics, Inc.
MPM BioImpact LLC
Gadicke Ansbert
UBS Oncology Impact Fund L.P.
MPM Asset Management LLC
MPM Oncology Innovations Fund GP LLC
iTeos Therapeutics, Inc.
TCR2 Therapeutics Inc
View All
Terms | Privacy | Providers | Guide
tony@aum13f.com